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Abstract
The field of bioengineering has much promise for renewable chemical production,
bioremediation, and of course medical applications. Developing new useful microorganisms
is extremely time and capital intensive, typically taking 50 million USD and eight years 1.
This is due in large part to the low throughput techniques that are characteristic of the field of
metabolic engineering 2,3. Here we describe the modification of an existing synthetic
biosensor to measure the pharmaceutical dopamine, and the use of a circuit simulator
Cadence to predict improvements to the biosensor. This biosensor paired with directed
evolution techniques could reach throughputs of 5 million cells per day and be a rapid avenue
for generating useful microbes at low cost.
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Introduction
Bioengineering has expanded its applications to produce cosmetics all the way to
pharmaceuticals. Despite the advances there remain many opportunities for biomanufacturing
in renewable fuels, synthetic materials, and bio-remediation, however widespread adoption
of biological manufacturing is hindered by technical, and economic sticking points. The state
of the art depends on laborious measurement techniques, typically takes 6-8 years, and $50
million dollars to develop new useful microbes1.
Lots of focus has been placed on the methods for introducing mutations and direct
engineering of the DNA. For example, the high-throughput technique for modifying genes
from the Church lab, multiplex automated genome engineering (MAGE) in its first study
established capability to engineer in mutations in the billions. However, their screening
technique, assuming 24 hour automated colony picking, could only screen ~50,000 cells per
day4. This technology was commercialized by the spinoff EnVolve, which was bought by
Zymergen, a growing biomanufacturer. Ginkgo Bioworks, another biomanufacturing
company, has a screening capability using an array of automated HPLC machines of
approximately 1000 to 10,000 cells per day (personal communication with Ginkgo
employee). Evolution stands as potentially the best tool to address the problems of biotech.
Artificial evolution techniques vastly accelerate screening, don’t require directed
modifications, which thereby allow us to sidestep our “profound ignorance” of the
relationship between genetic sequence and function, as Nobel laureate Francis Arnold has
repeatedly demonstrated3. To take a single antibacterial evolution paper, using fluorescent
activated cell sorting (FACS) researchers can sort at least 5 million cells per day, a factor of
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100 increase over MAGE 5. However, to use FACS, first a fluorescent signal must be
generated in proportion to the cells’ productivity.
This project focused on producing the small molecule pharmaceutical, dopamine
(DA) because it has an established global market, and a known biological pathway. Previous
researchers engineered E. coli to produce DA at 14 mM, so this was chosen as maximum
lower-bound value that the sensor must be sensitive to. We decided a minimum upper-bound
based on comparison to Ajinomoto Co. LTD’s commercially viable production of L-DOPA
at 100 mM. L-DOPA is a common Parkinson’s disease treatment, and in fact is converted to
DA within the brain which is where it takes effect6. However, DA does not cross the bloodbrain barrier and thus is not a treatment for the disease, instead DA is used in trauma settings
as a vasopressor7.
Here we describe the development of a biosensor to aid artificial evolution of
bacterial DA production. To link the DA productivity of our cells to a fluorescent signal and
enable FACS, we implement a positive slope logarithm biosensor, built off a positive
feedback and shunt (PFS) cellular circuit developed by previous researchers in the
Sarpeshkar Lab8. With this easy to use sensor, we hypothesize the best molecule producing
cells among a randomly assorted genetic population of millions can be determined by their
fluorescence, then evolved to be industrially useful.
Due to the global COVID-19 pandemic, directed evolution experiments could not be
performed. Instead we searched to computationally optimize the biosensor’s energy and
dynamics for future evolutionary work. We hypothesized that implementing a negative
regulator on the positive feedback on the low-copy number plasmid (LCP), and varying the
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ratio of the high to lower copy plasmids of the sensor would allow us to improve the
performance of the circuit.

Methods
Biological Sensor Construction
Dopamine
Tyr

The biological sensor, positive feedback
and shunt shown in Figure 1 was built off the
backbone of an existing arabinose sensitive PFS
biosensor, developed by the Sarpeshkar lab8.

PmaoA
PTPL
Dopamine
Tyr

maoR
TyrR

Dopamine
Tyr

Modifications were made to enable it to sense

PmaoA
PTPL

maoR
TyrR

Dopamine
Tyr

PTPL
PmaoA

the molecule dopamine, our desired product. As

PTPL
PmaoA

with most biological compounds, there exists a
DA

set of proteins and genetic sequences that are
sensitive to the molecule. The transcription

Figure 1. Positive slope logarithm, positive feedback
and shunt biosensor schematic. Top, low copy plasmid
(LCP), bottom high copy plasmid (HCP).

factor maoR was found by literature review to
act as a positive activator of DNA transcription from the promoter maoA (PmaoA) in the
presence of dopamine and other catecholamines9. The sequence for the gene maoR was taken
from this paper and then stitched together with the PmaoA sequence from Sugino et al.
199210. This sequence mashup was then found to have 99.63% homology to a sequence from
NCBI of the Klebsiella aerogenes strain NCTC9667 genome assembly, chromosome: 1. We
used these sequences for our PmaoA and maoR genes, which replaced the previous promoter
and transcriptional regulator.
Several variants of PmaoA were generated based off studies of promoter mutational
effects to establish relatively high (10,000 fold induction), medium (1000 fold induction),
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and low (100 fold induction) transcriptional levels11. These were designed to yield various
levels of positive feedback (PF) strength, and allow us to improve our log-linearity and input
dynamic range. The genetic sequences for maoR, and PmaoA were synthesized on g-blocks,
and the primers for modifying PmaoA, and PCR were synthesized by Integrated DNA
Technologies (IDT). The g-blocks and primers were designed to have 60 base pair overlap
regions to the PFS plasmids to help alleviate any priming issues due to the proximity to the
promoter and any secondary structures it may form.
We used NEB Q5 DNA polymerase to PCR amplify the g-blocks, and vector
backbones from the pRF124 low copy plasmid (LCP), and pRF131 high copy plasmid (HCP)
from the arabinose sensor reported in Daniel et al. 2013. Some PCR reactions were purified
with Qiagen PCR Cleanup kits, and others with non-target products as visualized by DNA
agarose gel electrophoresis were purified using Qiagen Gel purifications kits. Vector
backbone fragments were restriction enzyme digested with DpnI to remove any intact
template plasmids from the PCR reaction.
Digested vector backbone, and g-block fragments were assembled with NEB Gibson
assembly. Gibson assembly mixture of the PmaoA and maoR variants, and vector backbones
were transformed into NEB 10β chemically competent E. coli. The plasmids were recovered
via mini-prep and their identity was confirmed with Sanger sequencing. The two plasmids
were then co-transformed into chemically competent NEB 10β E. coli to form the active
biosensor.

Biosensor Evaluation
Evaluation of the biosensors was performed using a modified version of the protocol
described in8. In overview, the cells with the PFS plasmids are sub-cultured for 2-3 days to
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establish a healthy population. Then, the cells are added to a 96 well plate with a DA
gradient, incubated, and then read for fluorescent signal.
In detail, after the 2-3 day sub-culturing, a final overnight is grown in 5 mL of LB
media with 50 μg / mL of kanamycin, and carbenicillin antibiotics each to maintain the
plasmids. On the morning of the experiment we warm to 25 C a 2 mL Eppendorf tube of
frozen 100 mM dopamine in LB media kept at in a freezer box to avoid light degradation in 20 C, a 96 well black well clear bottom plate, and LB growth media.
To setup the dilution series and sensor test the following steps are performed.
Dopamine is highly sensitive to degradation by light and oxygen, thus the following work is
performed inside an anaerobic fermentation chamber. The desired dilution series spanned
from near its saturation point, 100 mM to 2.5 mM. To generate this series dopamine and LB
media, cells, and regular LB media are mixed in the volumes described in Table 1. Cell and
Media Mixing for Dilution Series. In column 1 of a 96 (8 x 12) well plate overnight cells are
added to LB + 100mM DA. For columns 2 through 12, a mixture of LB and cells is prepared
as described in Table 1, and 100 L are pipetted into wells 2 through 12. Then a 250/350th
serial dilution is performed by pipetting 250 L from a well in column 1 to a well in column
2, mixed, and then 250 L from that well into well 3, and so on and so forth. This establishes
a DA concentration gradient from 100 mM to 2.5 mM DA. To control against factors besides
DA in the media, an LB control is used in place of LB + DA media. To control against non
cell-based factors affecting our results a water control is used in place of the cells. A quick
visual check is then performed to see whether there is noticeable browning of the media
which would indicate the breakdown of the DA. Seeing no breakdown of DA, the plate is
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capped with the lid and then incubated in an anaerobic chamber at 25 C and shaken at 250
rpm for various durations of time.
Table 1. Cell and Media Mixing for Dilution Series

Plate Column 1

Plate Columns 2 through 12

Number of Reactions

1

1

12

Overnight Cells (L)

3.5

1

12

LB Media + DA (L)

350

0

0

LB Media (L)

0

100

1200

Before reading the sensor output, to check again whether the DA has degraded, we
inspect visually for browning of the media. Then the cell density is quantified by measuring
the light absorbance at 600 nm. To read the PFS output’s red fluorescent protein, mCherry,
the cells are excited with 580 nm light and the emission is measured at 617 nm using a
Molecular Devices SpectraMax Paradigm Multi-mode microplate reader. The data was
recorded in Excel and analyzed in MATLAB.

Fitting of Biological Data
Firstly, the biological data’s concentration was scaled up by 500,000 to put it in the
same range as the Cadence model. The data is then imported to Cadence Virtuoso, where the
model parameters are parametrically swept and adjusted so as to fit the curve to the
biological data. The final values that produced a good fit, as determined by simple
inspection, are tabulated in Table 2. Modeling parameter values for final fit to biological
data. Variable names, and values given for sensor developed in this study., in the appendix.
Notably this table shows the previous model parameter names because those elements in
Cadence need not be renamed, only their values changed to model the new biological system.
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On the left column are the biological elements of the biosensor developed in this study, and
on the right are the previous elements used by Daniel et al.

Negative Regulation of Positive Feedback in Biosensor Model
7. LacI production on
LCN plasmid

8. LacI and IPTG binding

3. pMAO_A and lacO on
LCP

6. Final maoR
accounting

5. Protein
storage and
degradation

1. Dopamine & maoR
binding
2. pMAO_A on HCN
plasmid

4. Multiplier attributes for
protection of DNA-bound maoR

Figure 2. Cadence schematic of positive feedback and shunt biosensor with LacI inhibition of positive feedback. Notably
Cadence element names are labeled as the original arabinose sensitive circuit, but these labels are meaningless from a
systems perspective because their dynamics are the same.

The electronic circuit modeling software Cadence was used to find the optimum
combination of power usage, on-off ratio, and log-linearity of the PFS biosensor. To improve
overall performance we added a negative regulator of the positive feedback (PF) and varied
the copy number ratio (CNR) of high to low copy number plasmids of the PFS (Figure 1,
Figure 10). We implemented this negative control by adding the lactose operon
transcriptional inhibitor lacI.
The first electronic version, without the lacI inhibition of positive feedback was constructed
in the course ENGS 162, and is described in Daniel et al. 2013. The addition of the lacI
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negative regulation of the positive feedback (PF) was realized by implementing a lacI
constitutive promoter, and transcription factor-inducer binding model, also from ENGS 162.
Integrating the output from the transcription factor-inducer binding model and the promoter
of the maoR transcription factor was done using the voltage divider rule (Eq. I). The addition
of the lacI binding to lacO acts to multiplicatively reduce the activating effect of the maoR
activator on the maoA promoter (Eq. II), and is assumed to have no loading effects. The
equations that describe these relationships are given below, where V is voltage, a proxy for
concentration, and the Kd values are equation constants that define the physical system. A
schematic of these circuits is shown in Figure 11 of the appendix.

Eq. I. Concentration of maoR complexed with DA and bound to the maoA promoter.

𝑉𝑚𝑎𝑜𝑅𝐶𝐵 =

𝑉𝑚𝑎𝑜𝑅𝐶
𝐾𝑑𝑚𝑎𝑜𝑅𝐶
𝑉𝑚𝑎𝑜𝑅𝐶
𝑉
1 + 𝑚𝑎𝑜𝑅 +
𝐾𝑑𝑚𝑎𝑜𝑅
𝐾𝑑𝑚𝑎𝑜𝑅𝐶

∗ 𝑉𝑝𝑙𝑎𝑠𝑚𝑖𝑑

Eq. II. Promoter flux in equal in magnitude to the voltage divider.

𝐼𝑚𝑎𝑜𝑅 = 𝑉𝑃𝑚𝑎𝑜𝐴 =

1
∗ 𝑉𝑚𝑎𝑜𝑅𝐶𝐵
𝑉𝑙𝑎𝑐𝐼
1+
𝐾𝑑𝑙𝑎𝑐𝐼

Performance and Energy Accounting
To account for energy, we recorded the current fluxes from protein production in the
Cadence Virtuoso simulator. This is the flux out of the first promoter, second promoter, and
in the case of lacI production, the lacI constitutive promoter. A more complete model would
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develop an energy accounting model for maintenance and replication of the plasmids, and
transcription of RNA. The energy usage of a given biosensor was taken to be the sum of the
steady state protein fluxes (as proxied by current) along the entire DA response curve. This
can be stated as such:

Eq. III..
𝑐2

𝐸𝑛𝑒𝑟𝑔𝑦 = ∑ Proteinflux (𝐷𝐴)
𝐷𝐴=𝑐1

We defined the on-off ratio as the ratio of the highest output signal divided by the
lowest output signal, as shown below.
Eq. IV.

𝑂𝑛 𝑡𝑜 𝑜𝑓𝑓 𝑟𝑎𝑡𝑖𝑜 = 𝑂𝑅 =

PFS(c2 )
𝑃𝐹𝑆(𝑐1 )

We defined the degree to which the curve was log linear by first logarithmically
fitting the data, and then taking the inverse of the of the root mean square error between the
log-linear fit and the sensor data.
Eq. V.

𝐿𝑜𝑔 𝑙𝑖𝑛𝑒𝑎𝑟𝑖𝑡𝑦 = 𝐿𝐿 =

1
𝑅𝑀𝑆𝐸

In our pursuit of the best sensor along the dimensions considered, we defined the cost
of a given sensor configuration as the ratio of the energy usage, to the weighted sum of the
on-off ratio and log-linearity. The weighting terms were chosen to put the average value of
the terms being weighted at the average value of the energy values.
Eq. VI. Cost function.

𝐶𝑜𝑠𝑡 =

Energy
𝑎1 ∗ 𝑂𝑅 + 𝑎2 ∗ 𝐿𝐿
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Being that we look for the best performer, we inverted the cost function to define our
figure of merit for any given biosensor version, as shown below.
Eq. VII. Figure of merit to quantify performance of Cadence biosensor model.

𝐹𝑖𝑔𝑢𝑟𝑒 𝑜𝑓𝑀𝑒𝑟𝑖𝑡 =

1
𝐶𝑜𝑠𝑡

The figure of merit was calculated and used to determine the best sensor
configuration for each IPTG concentration (inhibition of positive feedback) and CNR
evaluated in this study. To compare the various sensor versions, we plotted their figure of
merit as a function of the two inputs and performed a bilinear interpolation of the surface.

Construction of Biological Pathway
The construction of the biological pathway was previously described by Nakagawa et
al. 201412. The first plasmid pCT14 (Figure 9) that encodes the enzymes DDC and
Tyrosinase which produce dopamine from tyrosine Figure 3 was based off Nakagawa et al.
2014’s pAN349 plasmid description. The two genes DDC and Tyrosinase were constructed
on g-blocks by IDT, as were the primers for sequencing and PCR amplification. The g-blocks
were amplified by PCR, and gel-purified using Qiagen kits. The vector pET-23 PCR product
was digested with DpnI to remove background in-tact pET-23. The digested pET23 was
assembled with purified g-blocks via Gibson assembly. The assembly was transformed into
NEB 10β cells, and was verified assembled by colony PCR, however it awaits genetic
sequence verification from Sanger sequencing.

16
The second plasmid, pAN23 (Figure 9) that encodes the enzymes AroG, TyrA, ppsA,
and tktA which drive the overproduction of tyrosine (Figure 3) within E. coli was not
completed. The plasmid components were the vector backbone of pCOLA-Duet-1 obtained
from EMD Millipore, g-blocks of AroG, TyrA, and a small 250 bp connector to for the genes
ppsA and tktA. The genes tktA and ppsA were both amplified from wild type E. coli lysate.
which was prepared by heating cells in water to 50 C for ten minutes. The g-blocks and
vector backbone were amplified with Phusion DNA polymerase, and purified via gel or PCR
purification Qiagen kits depending on whether there were non-specific bands. We attempted
to assemble the five fragments by Gibson assembly, yet they were not assembled.

Tyr

DDC

Figure 3. Genes and the pathway they encode for E. coli dopamine production. Figure adapted from Nakagawa et al. 2014.
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Results
Dopamine Pathway
The enzymes necessary for enabling
Standard

E. coli to produce DA were constructed in E.

pCT14 Colony PCR

8 kb

coli, which we confirmed by colony PCR
6 kb

(Figure 4) though verification by sequencing
was not completed. The genes responsible for
overproducing the input to DA synthesis,
were not assembled.

Figure 4. Dopamine production plasmid (pCT14) colony
PCR. NEB 2 log-ladder standard on left, with colony PCR of
pCT14 transformant.

In-Vivo Biosensor Evaluation
We tested two of the biosensor

6

10

versions, one with the wild type (WT)
5

5

Biological Sensor Dynamics
WT
WT - Neg CTRL
1e2 Induction
1e2 Induction - Neg CTRL
Desired Lower Bound
Desired Upper Bound

PmaoA promoter sequence, the second
modified to have a relatively low strength
100 fold induction of the promoter11. The

RFU / A600

4

3

2

variants were generated after the WT K.
1

aerogenes PmaoA was shown to not
0
10 -3

operate correctly over the entire
concentration range of interest (Figure 5).
However we showed that the low induction

10 -2

10 -1

Dopamine (M)

Figure 5. In-vivo bio-sensor dynamics for wild type PmaoA
and relative low strength PmaoA variant with an intended
promoter induction ratio of 100. Negative controls of cells
with no added dopamine are given, as well as vertical bars
for the concentration range of interest.

version in yellow has log-linear behavior over the concentration range of interest, and can be
fit by the function given in Equation VIII. Final sensor fit using a base 10 logarithm.

10 0
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Equation VIII. Final sensor fit using a base 10 logarithm.

𝑚𝐶ℎ𝑒𝑟𝑟𝑦 = 94040 ∗ log(𝐷𝐴) − 223610

Electronic Fit of Biological Data
A good fit of the model to the

4

10

5

Fit of Cadence PFS to Bio PFS
Cadence PFS
Bio PFS
Log-Linear Fit

3.5

varying the binding coefficient Kd of
PmaoA, the forward binding Kd of maoA
and DA, and scaling the biological
concentration 500k up. We settled on a
final fit by visual inspection of the

mCherry Fluorescence (volts)

biological data was obtained by primarily

3

2.5

2

1.5

1

0.5
10 3

10 4

10 5

10 6

Dopamine (volts)

biological and simulated data. We took the
results shown in Figure 6 to be an effective

Figure 6. Fit of Cadence model to biological data of the biosensor,
and a log-linear best fit to the biological data. Scaled dopamine
concentration by 500k.

model of the system, from which we could do prediction. The values used for the final fit are
given in the appendices, Table 2. Modeling parameter values for final fit to biological data.
Variable names, and values given for sensor developed in this study..
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In-Silica Performance Optimization of Biosensor
Performance Function
3.5

1.6

mCherry Fluorescence (volts)

1.8

10 5

Performance Function

IPTG Concentration (Volts)

2.4

2

Best PFS-I Version

3

2.6

2.2

5

CNR = 26.7, IPTG = 3e+05 (volts)
Log-Linear Fit

2.8

10 6

10

2.5

2

1.5

1

1.4

1.2

10

4

0.5

1

20

25

30

35

40

45

50

Copy Number Ratio (CNR)

Figure 8. Heat map of bilinear interpolated figure of merit.

0
10 2

10 3

10 4

10 5

10 6

Dopamine (volts)

Figure 7. Optimized sensor version corresponding to 'hot
spot' of the heat map figure with log-linear best fit curve.

We quantified the results of our comparison of sensors’ performance by our figure of
merit given as the weighted ratio of log-linearity and on-off ratio to energy (see Eq. III, Eq.
IV, Eq. V, Eq. VI, Eq. VII for calculation). The results, plotted in Figure 8 clearly show that
the best performance is achieved at a relatively low CNR of 26.7, which is not too different
than the version that fit the bio’s data, with a CNR of 33.3. It also showed that an
intermediate IPTG concentration affecting an intermediate level of PF inhibition on the low
copy plasmid is optimal. Thus, we showed that in-silica both the CNR and PF inhibition are
effective parameters for improving performance. The weights that used to define a1 and a2 in
Eq. VI are 3.7e+11, and 5.1e+7 for respectively. The final optimized sensor version is shown
in Figure 7.

Discussion and Future Work
Firstly, we showed that an effective biosensor to the small molecule dopamine can be
easily fashioned by refitting the positive-slope logarithm biosensor developed by Daniel et al.
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2013. This sensor was shown to be sensitive to DA over the required operational range, and
deliver strong-log linear behavior.
Our computational analysis elucidated a path for optimizing the overall performance
in-vivo of the sensor measured in energy usage, its log-linearity, and on-off ratio. Further we
hypothesize that in-vivo, adding lacI and lacO as negative regulators of the circuit would
allow us to turn the circuit off during long term evolution studies, thus significantly reducing
the selective pressure to eliminate it. Additionally, this negative regulator would allow us to
turn on the sensor only when we’re ready to read the cells, and thus remove differences in
signal dynamics that may exist between our short term (hours) test of the sensor versus the
long (days) incubation needed for directed evolution.
The dopamine synthesis genes were constructed and transformed into E. coli. The
tyrosine overproduction genes were not assembled, though future troubleshooting or redesign of the plasmids could fix this. Alternatively, the dopamine production from the strain
with DA synthesis genes could be measured to determine whether it generates DA in the
functional range of the sensor, and if so, evolutionary experiments could begin without
troubleshooting the overproduction plasmid.
The sensor and dopamine productions plasmids would be co-transformed into E. coli.
These cells would then be exposed to random mutagenesis, generating a diverse population.
Then after sufficient incubation to generate a concentration of dopamine detectable by the
sensor we would stop the incubation and screen the cells. To evolve the cells we would first
determine the distribution of sensor signal strength in the population. Then, some fraction of
the strongest signal cells would be screened out with a second run through the FACS
machine. These cells would then be further mutated and screened. Applied iteratively,
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generating diversity and selecting the best producers will evolve cells to be ever more
productive, and eventually reach the yield, titer, and rate requirements for industrial
biological production. Notably, our proposed method eliminates the need for design of
genetic modifications, implementing and verifying those genetic modifications, and the
setback of being wrong about genetic designs. Further, we hypothesize the biosensor will
enable high-throughput FACS evolution of up to 5 million cells per day.

Potential Problems and Candidate Solutions
Our experiments showed that the absolute signal output of the biosensor value may
change some across experiments (data not reported). In response to this it’s important to note
that the sensor will be able to tell relatively better producers, but may be less accurate with
regards to absolute concentration. To increase the selective pressure for evolving increased
DA production, the circuit could be modified to make it a negative-slope logarithm as
reported in Daniel et al. 2013, such that as concentration increases the output signal
decreases. Lower output signal means lower metabolic footprint, and thus provides an
energetic advantage to those that are more productive (lower signal) over the less productive
(higher signal) cells. Further development of reward-based evolution could provide an
auxotrophic strain the capability to generate the molecule it’s auxotrophic for, or
alternatively enabling it to metabolize an additional energy source. The enzyme would
become the output of the PFS circuit, whose topology would keep the enzyme proportional to
the DA concentration.
With regard to the DA itself, there is reasonable concern that the DA won’t stay
localized enough to a cell for a cell’s signal to be only a function of the local DA production.
In response to this, it may well be possible to simply dilute the cells such that the DA
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production from the other cells is far enough that it will effectively not affect the local
concentration (conversation with Karl Griswold, Thayer School of Engineering). Further, one
option is to encapsulate the cells in gel micro-droplets (GMDs) of agarose gel developed by
Scanlon et al. 2014, and growth media. Then these microdroplets would be incubated in
mineral oil to prevent the diffusion of DA from the aqueous GMDs to other GMDs and their
local population. This would thus co-localize DA production genotype with the fluorescent
phenotype established by the biosensor, allowing effective screening.
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Appendices
Table 2. Modeling parameter values for final fit to biological data.
Variable names, and values given for sensor developed in this study.
This Study

Daniel et al. 2013

This Study

Dopamine sensitive

Arabinose sensitive

Value

Capacitance

Capacitance

1

basal promoter current

basal promoter current

26m

h1_DA

h1_arab

1

h2_DA

h2_arab

500m

Kd1_DA

Kd1_arab

1.3k

Kd2_DA

Kd2_arab

200

Kd_PmaoA

Kd_pBAD

1.75k

Kdf_PmaoA

Kdf_pBAD

1.26k

HCP Number

HCP Number

1k

LCP Number

LCP Number

30

R_maoR

R_araC

100

R_mCherry

R_mCherry

1.75k

Theta

theta

150m
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Figure 9. Plasmids pAN23 for tyrosine overproduction, and pCT14 for dopamine production. pAN23 file from personal
communication with Akira Nakagawa, Ishikawa Prefectural University, Japan. Plasmid images from Benchling.com.
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Figure 10. Low copy plasmid (pCT07, top) and high copy plasmid (pCT10, bottom). Images generated from
Benchling.com.
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A)

B)

Figure 11. PmaoA and LacO to reduce positive feedback of biosensor. A, the maoR and maoR_C binding dynamics; B, the
lacI binding inhibition dynamics.

𝑉𝑚𝑎𝑜𝑅

A) 𝑉𝑚𝑎𝑜𝑅𝐶𝐵 =

𝐶 )
(𝐾𝑑
𝑚𝑎𝑜𝑅𝐶
𝑉

1 + (𝐾𝑑𝑚𝑎𝑜𝑅 )

ℎ𝑚𝑎𝑜𝑅

𝑚𝑎𝑜𝑅

𝐵) 𝐼𝑚𝑎𝑜𝑅 = 𝑉𝑃𝑚𝑎𝑜𝐴 =

ℎ𝑚𝑎𝑜𝑅𝑐

𝑉𝑚𝑎𝑜𝑅

+ (𝐾𝑑

ℎ𝑚𝑎𝑜𝑅
𝑐

∗ 𝑉𝑝𝑙𝑎𝑠𝑚𝑖𝑑

𝐶 )
𝑚𝑎𝑜𝑅𝐶

1
𝑉𝑙𝑎𝑐𝐼 ℎ𝑙𝑎𝑐𝐼
1 +(
)
𝐾𝑑𝑙𝑎𝑐𝐼

∗ 𝑉𝑚𝑎𝑜𝑅𝐶𝐵

Note that the Hill coefficients, h are set to 1, and thus A and B simplify to Eq. I and Eq. II
respectively.
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